(Bloomberg) -- Seventy coronavirus vaccines are in development, with three being tested in human trials, the World Health Organization The outbreak has stabilized across the U.S., according to the head of the Centers for Disease Control and Prevention.Parts of the U.S. may be ready to ease emergency measures in May, said Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. U.K. Prime Minister Boris Johnson praised doctors for saving his life during his week-long hospitalization for Covid-19 treatment.Futures on the three main U.S. equity indexes all dropped, while stocks fell in Asia’s main financial centers. Markets across Europe were closed for the Easter holiday.Key DevelopmentsCoronavirus Tracker: Global cases reach 1.85 million; deaths top 114,00070 coronavirus vaccines in development globallySpain reports smallest number of new infections since March 20Fauci says U.S. reopening could start ‘in some ways’ in MayCruise passengers spend Easter on “ghost ship”The Virus Should Wake Up...
Shares in Athersys, Inc. (ATHX) soared more than 20% in U.S. premarket trading after the biotech company announced that it was granted approval by the Food and Drug Administration (FDA) to start a pivotal clinical study of its stem-cell therapy on patients with COVID-19-induced acute respiratory distress syndrome (ARDS).Following the FDA approval, Athersys said it plans this quarter to initiate a phase 2/3 pivotal study to determine the safety and efficacy of its MultiStem therapy in coroanavirus patients with moderate to severe acute respiratory distress syndrome. The study conducted among 400 individuals will be administered at leading pulmonary critical care centers throughout the U.S., the company announced. According to the World Health Organization (WHO) and other recent clinical and epidemiological data, ARDS is the leading cause of death among COVID-19 infected patients.“We believe that MultiStem treatment, by modulating patients’ hyperinflammatory response to highly pathogenic respiratory viruses, including SARS-CoV-2 which causes COVID-19,...
(Bloomberg) -- After a week-long marathon of calls between world leaders and video conferences featuring dozens of energy ministers, it was the moment the 2020 oil price war finally ended.From Villahermosa, a city near Mexico’s largest crude terminal, Energy Minister Rocio Nahle raised her voice. “Your Royal Highness, Mexico has already agreed. And now I would like to ask you: ‘Do you agree with these terms?’”In Riyadh, Saudi Energy Minister Prince Abdulaziz bin Salman nearly chuckled as he looked at a wall of video feeds showing his counterparts around the world. “I go with the consensus. I agree,” he replied.At that moment, the OPEC+ alliance sealed the largest ever coordinated production cut, removing about a 10th of global supply. The historic deal had almost been derailed by a fight between Saudi Arabia and Mexico’s populist government, forcing President Donald Trump to step in and broker a face-saving solution.Prince Abdulaziz declared himself...
